Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase NA 12Phase 3 8Phase 4 6Phase 2/3 5Phase EARLY_PHASE1 3Phase 1 3Phase 1/2 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Glioblastoma 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 155Carboplatin 147Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 119Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Tablets × Clear all
NCT07435584 2026-02-27

EVER-RECODE

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting
38 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04772846 2021-02-26

Chloroquine for Glioblastoma.

Egyptian Medical Syndicate

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡